GenDx

GenDx is a biotechnology company that specializes in high-resolution HLA (human leukocyte antigen) typing and molecular diagnostic testing. Founded in 2005 by Dr. Erik Rozemuller and Dr. Wietse Mulder, the company develops and markets innovative diagnostic tests primarily for transplantation and immunogenetics. GenDx offers advanced molecular diagnostic services and products that enable precise HLA typing, which is essential for matching organ and stem cell donors with recipients. Their product portfolio includes kits and software solutions designed for accurate, high-throughput HLA genotyping, utilizing advanced molecular biology and bioinformatics technologies. GenDx serves clinical laboratories, transplant centers, research institutions, and biotechnology companies, supporting improved patient care in transplantation medicine through better donor-recipient matching and immune response monitoring.

• Employees71
• Founded2005
• Annual Revenue$19250000